查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1912753

智慧氣喘監測設備市場（按設備類型、監測技術、連接方式、性別、最終用戶和分銷管道分類）—2026-2032年全球預測

Intelligent Asthma Monitoring Devices Market by Device Type, Monitoring Technology, Connectivity, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年智慧氣喘監測設備市值為5.7527億美元，預計到2026年將成長至6.3735億美元，到2032年將達到13.2027億美元，複合年成長率為12.60%。

關鍵市場統計數據
基準年 2025 5.7527億美元
預計年份：2026年 6.3735億美元
預測年份 2032 1,320,270,000 美元
複合年成長率 (%) 12.60%

掌握智慧氣喘監測的現代趨勢，感測器融合、互聯互通和臨床需求正在重新定義病患管理和護理服務。

氣喘治療領域正經歷著至關重要的技術變革，這場變革的驅動力來自微型感測器、無所不在的網路連接以及先進的數據分析技術的融合。從臨床環境到家庭環境，智慧監測設備正從試驗階段走向診療路徑的常規應用，實現持續的生理評估、藥物依從性追蹤以及環境風險檢測。這項轉變的促進因素包括：臨床醫生對客觀縱向數據的日益成長的需求、患者對減少氣喘發作和提高自主性的渴望，以及支付方對基於績效的報銷模式的尋求。

明確推動智慧氣喘護理設備設計、數據整合和推廣應用路徑的核心技術、臨床和市場促進因素。

目前智慧氣喘監測的發展現況正受到多項變革性因素的影響，這些變革不僅加速了其普及應用，同時也提高了設備效能和實證依據的標準。首先，感測器技術日益成熟和多樣化，使設備能夠捕捉喘息的聲學特徵、透過生物感測器檢測生化標誌物，並透過整合吸入感測器監測患者行為。這種技術上的廣度使得監測系統能夠應對各種應用場景，從即時檢測病情加重到驗證用藥依從性，再到提供個人化的環境警報。

分析近期關稅調整和貿易政策轉變如何加劇智慧氣喘設備生態系統的供應鏈複雜性、成本壓力和策略採購選擇。

2025年實施的關稅和貿易政策調整對智慧氣喘監測設備的產品開發、採購和定價策略帶來了複雜的壓力。由於許多核心零件，例如微機電系統（MEMS）、專用生物感測器元件、無線通訊模組和特定印刷基板組件等，都來自全球供應鏈，進口關稅的增加推高了到岸成本，迫使製造商重新評估其籌資策略。因此，企業必須在自行承擔額外成本、將其轉嫁給買家或重組供應鏈以降低風險之間做出選擇。

透過產品、技術、連接方式、最終用戶和分銷管道的細分，揭示智慧氣喘解決方案的差異化設計重點和商業化路徑。

細分市場分析揭示了不同設備類型、監測技術、連接方式、最終用戶和通路所帶來的獨特需求促進因素和設計要務。設備分類包括臨床級和家用固定式監測器，每種監測器對精度、校準和資料安全的要求各不相同。行動應用程式支援患者參與和遠端監測工作流程。智慧吸入器包括劑量計數器和吸入器技術感測器，劑量計數器又可進一步分為電子式和光學式，而吸入器技術感測器則採用基於流量或壓力的方法。穿戴式追蹤器種類繁多，從黏貼式貼片到腕帶，其中黏貼式貼片本身就滿足了不同的用戶需求，因此需要同時關注黏合劑的化學性質和綁帶的替代方案。這些設備差異將影響監管路徑、臨床檢驗方法和可用性設計重點。

評估醫療保健結構、管理體制和基礎設施的區域差異如何影響智慧氣喘監測的採用策略和商業化。

區域趨勢將對智慧氣喘監測的普及速度、監管預期和商業模式產生重大影響。在美洲地區，人們對能夠展現明確臨床療效並可與現有電子健康記錄 (EHR) 基礎設施整合的設備表現出濃厚的興趣。支付方的討論主要集中在將設備使用與減少急診就診量掛鉤的報銷模式上，旨在促進設備製造商與醫療系統之間的合作。此外，美洲地區對可擴展的遠距監測計畫需求強勁，這些計畫透過利用遠端醫療的服務包來滿足農村和醫療服務不足地區的需求。

呼吸監測領域設備製造商、軟體創新者和醫療保健系統合作者的競爭定位、聯盟趨勢和能力集中度分析

智慧氣喘監測領域的競爭格局錯綜複雜，既有成熟的醫療設備公司，也有新興的數位醫療Start-Ups，以及來自其他產業的科技參與企業。領先的參與企業正致力於透過提升感測器精度、增強軟體功能、產生臨床證據以及與現有醫療流程無縫整合來實現差異化競爭。設備製造商與臨床網路之間建立策略聯盟十分普遍，這有助於加速檢驗和收集真實世界證據，從而為醫保報銷談判提供支援。

為製造商、支付方和臨床合作夥伴提供最佳化產品模組化、證據產生、互通性和供應鏈彈性的實用策略

產業領導者應採取多管齊下的方法，使產品開發與臨床工作流程、支付方期望以及穩健的供應鏈策略保持一致。首先，他們投資於模組化平台，實現感測器互換和韌體升級，從而延長設備生命週期並降低長期總擁有成本。將模組化融入設計，使企業能夠在保護產品投資的同時，快速回應技術進步和監管回饋。

概述一種嚴謹的混合方法研究方案，該方案結合了關鍵相關人員訪談、二手證據綜合和專家檢驗，以獲得可操作的市場洞察。

為確保研究結果的穩健性和相關性，本研究採用了多層次的調查方法。主要研究包括對臨床醫生、設備開發人員、採購專業人員和分銷合作夥伴進行結構化訪談，以收集關於臨床效用、採購障礙和最終用戶體驗的實際觀點。次要研究則整合了監管文件、技術白皮書和同行評審文獻，以闡明設備性能特徵和監管趨勢的背景。

總之，我們的綜合分析表明，感測器、分析技術和營運策略的整合是推進所有醫療保健機構中智慧氣喘護理的關鍵因素。

智慧氣喘監測設備在臨床需求、技術可能性以及不斷變化的健康和經濟獎勵的交匯點上發揮關鍵作用。該市場的未來與其說取決於單一的技術創新，不如說取決於相關人員能否將可靠的感測器、強大的連接性和具有臨床意義的分析功能整合到工作流程中，從而為患者和醫療服務提供者帶來可衡量的價值。隨著技術的成熟，我們預計，證據產生、互通性和使用者體驗將成為推動產品普及的主要因素。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的智慧氣喘監測設備市場

  • 固定顯示器
  • 行動應用
  • 智慧吸入器
  • 穿戴式追蹤器
    • 修補
      • 黏合劑類型
      • 帶子
    • 腕帶

9. 依監測技術分類的智慧氣喘監測設備市場

  • 聲波感測器
  • 生物感測器
    • 化學
    • 光學的
  • 數據分析
  • 環境感測器

第10章 智慧型氣喘監測設備市場：連結性與性別

  • Bluetooth
    • BLE
    • 經典的
  • 細胞
  • Wi-Fi
    • Wi-Fi 5
    • Wi-Fi 6

第11章 以最終用戶分類的智慧氣喘監測設備市場

  • 診所
  • 居家照護
  • 醫院
  • 研究所

第12章 智慧氣喘監測設備市場（依分銷通路分類）

  • 直銷
  • 批發商
  • 線上零售

第13章 智慧氣喘監測設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 智慧氣喘監測設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國智慧氣喘監測設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國智慧氣喘監測設備市場

第17章：中國智慧氣喘監測設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Adherium Limited
  • AptarGroup, Inc.
  • GE HealthCare Technologies Inc.
  • Health Care Originals, Inc.
  • Koninklijke Philips NV
  • Microlife Corporation
  • NDD Medical Technologies, Inc.
  • Nihon Kohden Corporation
  • NuvoAir AB
  • Omron Healthcare Co., Ltd.
  • Phosphorus, Inc.
  • ResMed Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vitalograph Ltd.
Product Code: MRR-AE420CB13A77

The Intelligent Asthma Monitoring Devices Market was valued at USD 575.27 million in 2025 and is projected to grow to USD 637.35 million in 2026, with a CAGR of 12.60%, reaching USD 1,320.27 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 575.27 million
Estimated Year [2026] USD 637.35 million
Forecast Year [2032] USD 1,320.27 million
CAGR (%) 12.60%

Framing the contemporary dynamics of intelligent asthma monitoring where sensor convergence, connectivity, and clinical demand redefine patient management and care delivery

The landscape of asthma care is undergoing a decisive technological evolution driven by the convergence of miniaturized sensors, ubiquitous connectivity, and advanced data analytics. Across clinical settings and home environments, intelligent monitoring devices are transitioning from pilot deployments to integral elements of care pathways, enabling continuous physiological assessment, adherence tracking, and environmental risk detection. This transition is motivated by rising expectations from clinicians for objective longitudinal data, by patients seeking fewer exacerbations and greater autonomy, and by payers exploring outcomes-driven reimbursement models.

Emerging device classes-ranging from fixed clinical monitors to wearables and smart inhaler systems-are redefining how respiratory status is captured and acted upon. Alongside hardware improvements, software capabilities for signal processing, predictive algorithms, and user engagement are maturing, creating new opportunities for early intervention and personalized management. As a result, stakeholders across the value chain are recalibrating priorities: manufacturers must integrate multidisciplinary engineering, regulatory and clinical expertise; health systems must design workflows that translate device data into care decisions; and regulators are adapting frameworks to encompass connected diagnostics and therapeutic adjuncts.

Consequently, the introduction sets the stage for a pragmatic assessment of technological readiness, operational barriers, and the market behaviors that will determine which device profiles and business models achieve clinical traction. In the sections that follow, readers will find a synthesis of transformative shifts, trade-related pressures, segmentation intelligence, regional nuances, competitive dynamics, and concrete recommendations to inform strategic planning and investment decisions.

Identifying the pivotal technological, clinical, and market forces that are reshaping device design, data integration, and adoption pathways in intelligent asthma care

The intelligent asthma monitoring landscape is shaped by several transformative shifts that collectively accelerate adoption while raising the bar for device performance and evidence. First, sensor technology is becoming more robust and diversified, enabling devices to capture acoustic signatures of wheeze, biochemical markers via biosensors, and patient behaviour through integrated inhalation sensors. This technical breadth allows monitoring systems to address distinct clinical use cases, from real-time exacerbation detection to adherence verification and personalized environmental alerts.

Second, connectivity paradigms have matured beyond simple telemetry toward resilient, low-latency architectures that support edge processing, intermittent synchronization, and longitudinal data aggregation. This evolution reduces clinician burden by enabling concise, clinically relevant summaries rather than raw data streams. Third, software and analytics are driving value through predictive models and actionable insights that prioritize interventions with the greatest clinical impact. The integration of data from environmental sensors further enriches contextual understanding, linking triggers to physiological response and allowing for more precise patient counseling and targeted interventions.

Additionally, clinical acceptance is increasingly contingent on demonstrable outcomes and interoperability. Stakeholders now expect devices to produce validated endpoints that can be integrated into electronic health records and care pathways. Emerging reimbursement frameworks and value-based care initiatives emphasize measurable reductions in exacerbations and emergency utilization, thereby incentivizing devices that can generate reliable evidence. Finally, end-user experience-encompassing device ergonomics, ease of setup, and data privacy assurances-has become a decisive differentiator for broader market acceptance, especially in home care and consumer-facing segments.

Analyzing how recent tariff adjustments and trade-policy shifts have amplified supply chain complexity, cost pressures, and strategic sourcing choices across the intelligent asthma device ecosystem

The imposition of tariffs and trade-policy adjustments in 2025 has introduced a complex set of pressures that reverberate across product development, procurement, and pricing strategies for intelligent asthma monitoring devices. Because many core components-such as microelectromechanical systems, specialized biosensor elements, wireless communication modules, and certain printed circuit assemblies-are manufactured in global supply hubs, escalated import duties increase landed costs and compel manufacturers to reassess sourcing strategies. Consequently, firms face a choice between absorbing incremental costs, passing them through to buyers, or restructuring supply chains to mitigate exposure.

In practice, some manufacturers have responded by accelerating supplier diversification and qualifying alternate vendors in tariff-exempt jurisdictions. Concurrently, others have shifted investment toward regional manufacturing or assembly capacity to reduce cross-border dependencies and improve control over quality and lead times. These adjustments often require capital expenditure and lead-time investment, but they can enhance resilience and provide strategic flexibility in the medium term. Meanwhile, distributors and channel partners report tighter margin pressure, which affects promotional activities and the economics of bundled offerings that combine hardware, software subscriptions, and services.

Regulatory compliance and documentation requirements have also become more scrutinized at customs checkpoints, increasing administrative overhead for companies that rely on cross-border shipments of prototype and pre-production units for clinical trials. For early-stage innovators, these additional frictions can slow clinical validation timelines and create funding runway challenges. On the demand side, health systems and payers are increasingly sensitive to total cost of ownership, prompting procurement teams to seek devices with longer lifecycle support, modular upgrade paths, and clear evidence of reduced downstream costs. Therefore, the cumulative impact of tariff dynamics is a heightened emphasis on operational agility, localization where feasible, and contractual structures that balance risk across supply chain partners.

Deconstructing product, technology, connectivity, end-user, and distribution segments to reveal differentiated design priorities and commercialization pathways for intelligent asthma solutions

Segment-level analysis reveals distinct demand drivers and design imperatives across device types, monitoring technologies, connectivity modalities, end users, and distribution routes. Within device typologies, fixed monitors occupy both clinical grade installations and home-based deployments, each with divergent requirements for accuracy, calibration, and data security; mobile applications support patient engagement and remote monitoring workflows; smart inhalers include dose counters and inhalation technique sensors, with dose counters further differentiated into electronic and optical counters while inhalation technique sensors utilize flow or pressure-based modalities; wearable trackers range from adhesive patches to wristbands, and adhesive patches themselves demand attention to both adhesive chemistry and strap alternatives to accommodate diverse user needs. These device variations dictate regulatory trajectories, clinical validation approaches, and usability design priorities.

From a technology standpoint, acoustic sensors, biosensors, data analytics, and environmental sensors contribute complementary insights. Biosensors bifurcate into chemical and optical implementations, each with trade-offs in specificity, calibration needs, and integration complexity. Connectivity choices-including Bluetooth with BLE and Classic variants, cellular solutions, and Wi-Fi with Wi-Fi 5 and Wi-Fi 6 profiles-shape device power budgets, data throughput, and deployment scenarios, particularly where continuous monitoring or high-fidelity signal capture is required.

End-user segmentation-spanning clinics, home care settings, hospitals, and research laboratories-introduces distinct expectations for integration, service-level agreements, and clinical workflows. Distribution channels such as direct sales, distributor networks, online retail platforms, and pharmacies influence pricing transparency, after-sales support models, and the feasibility of bundled service offerings. Taken together, this segmentation mosaic underscores that a one-size-fits-all product strategy is unlikely to succeed; rather, winning propositions will tailor sensor selection, connectivity stacks, and user experiences to defined clinical and commercial segments while ensuring modularity to adapt to evolving requirements.

Evaluating how regional healthcare structures, regulatory regimes, and infrastructure variances shape adoption strategies and commercialization for intelligent asthma monitoring

Regional dynamics materially influence adoption rhythms, regulatory expectations, and commercial models for intelligent asthma monitoring. In the Americas, there is pronounced interest in devices that demonstrate clear clinical outcomes and integrate with existing electronic health record infrastructure. Payer conversations increasingly center on reimbursement models that align device usage with reduced acute care utilization, motivating collaborations between device makers and health systems. Moreover, the Americas exhibit a strong appetite for scalable remote monitoring programs that address rural and underserved populations through telehealth-enabled service bundles.

In Europe, the Middle East and Africa, regulatory harmonization and nuanced national reimbursement frameworks require tailored market entry strategies. Health technology assessment processes and data protection regulations prompt device developers to prioritize clinical evidence and robust privacy controls. Meanwhile, demand in certain MEA markets is shaped by infrastructure constraints and the need for solutions that operate reliably in variable connectivity environments, favoring devices with flexible synchronization and offline data capture capabilities.

Asia-Pacific presents a heterogeneous landscape characterized by rapid technology adoption in urban centers, a growing middle class seeking digital health services, and robust manufacturing ecosystems. This region often acts as both a market and a supply base, offering competitive component sourcing but also exposing companies to trade-policy volatility. Across all regions, successful strategies balance local clinical validation, partnership with established care providers, and adaptive distribution models that reflect payer mix and procurement practices.

Mapping competitive positioning, partnership trends, and capability concentration among device makers, software innovators, and health system collaborators in respiratory monitoring

Competitive dynamics in the intelligent asthma monitoring space are shaped by a mix of established medical device firms, emergent digital health startups, and cross-sector technology entrants. Leading entrants focus on differentiating through sensor accuracy, software sophistication, clinical evidence generation, and seamless integration with care workflows. Strategic partnerships between device manufacturers and clinical networks are common, enabling accelerated validation and real-world evidence collection that supports reimbursement discussions.

Mergers and collaborations have concentrated capabilities in areas such as advanced signal processing, cloud-based analytics, and secure interoperability frameworks. Startups often compete on agility and user-centric design, while incumbents leverage regulatory experience and scale to support large institutional deployments. Investors and corporate development teams are watching for platforms that reduce friction for clinicians-those that translate continuous device signals into actionable clinical alerts and integrate with care pathways without increasing workload.

Intellectual property around sensor modalities, algorithmic approaches to exacerbation prediction, and methods for ensuring data integrity is a distinguishing factor. In parallel, data privacy, cybersecurity posture, and compliance with health-data regulations remain core requirements that influence partnership selection and procurement. Ultimately, companies that combine robust clinical validation, scalable software platforms, and clear value propositions for payers and providers will gain preferential access to institution-level contracts and long-term reimbursement arrangements.

Actionable strategies for manufacturers, payers, and clinical partners to optimize product modularity, evidence generation, interoperability, and supply chain resilience

Industry leaders should pursue a multifaceted approach that aligns product development with clinical workflows, payer expectations, and resilient supply-chain strategies. First, invest in modular platforms that allow for sensor interchangeability and firmware upgrades to extend device lifecycles and reduce long-term total cost of ownership. By designing for modularity, companies can adapt rapidly to technology advances and regulatory feedback while protecting product investments.

Second, prioritize clinical validation pathways that generate actionable, peer-reviewed evidence demonstrating reductions in exacerbations, emergency visits, or medication overuse. Close collaboration with health systems for pragmatic trials and real-world evidence studies will accelerate reimbursement dialogues and broaden clinical adoption. Third, strengthen data interoperability by implementing standards-based APIs and working toward seamless integration with electronic health records and remote patient monitoring portals to reduce friction for clinicians.

Fourth, address supply-chain risk by qualifying multiple suppliers, exploring regional assembly options, and embedding tariff sensitivity into sourcing decisions to maintain price competitiveness. Fifth, focus on the end-user experience through human-centered design to improve adherence and minimize device abandonment; simple onboarding, clear feedback loops, and trustworthy privacy communications are essential. Finally, cultivate strategic partnerships with distribution channels that align incentives, whether through direct sales for institutional contracts or omnichannel approaches that combine online retail and pharmacy collaborations for consumer-facing deployments.

Outlining a rigorous mixed-method research approach that integrates primary stakeholder interviews, secondary evidence synthesis, and expert validation for actionable market intelligence

The research underpinning these insights combined a layered methodology to ensure robustness and relevance. Primary research involved structured interviews with clinicians, device developers, procurement specialists, and distribution partners to capture frontline perspectives on clinical utility, procurement barriers, and end-user experience. Secondary research synthesized regulatory documents, technology white papers, and peer-reviewed literature to contextualize device performance characteristics and regulatory trends.

Data triangulation was applied to reconcile divergent stakeholder views and validate thematic findings through cross-referencing of interview insights with secondary evidence. Expert panel reviews provided iterative feedback on analytic assumptions, ensuring that interpretations of technology readiness, clinical adoption barriers, and regional nuances were grounded in practitioner realities. Quality control measures included methodological transparency, documentation of interview instruments, and systematic coding of qualitative data to surface recurring patterns.

Finally, segmentation mapping linked product attributes, technology choices, and connectivity profiles to end-user needs and distribution models, enabling practical recommendations. The research avoided reliance on single-source proprietary estimates and emphasized evidence-based, reproducible analysis to support strategic decision-making.

Concluding synthesis highlighting the integration of sensors, analytics, and operational strategies as the decisive factors in advancing intelligent asthma care across care settings

Intelligent asthma monitoring devices occupy a pivotal role at the intersection of clinical need, technological capability, and evolving health-economic incentives. The trajectory of this market will be determined less by single innovations and more by the ability of stakeholders to integrate reliable sensors, resilient connectivity, and clinically meaningful analytics into workflows that deliver measurable value to patients and providers. As technology matures, emphasis will shift to evidence generation, interoperability, and user experience as primary determinants of adoption.

Organizations that proactively manage supply-chain exposures, design for modularity, and prioritize collaborative clinical validation will be best positioned to capture durable opportunities. Meanwhile, regional nuances in regulation, reimbursement, and infrastructure demand adaptive commercial strategies. By focusing on these strategic imperatives, manufacturers, payers, and clinical leaders can convert technological potential into practical improvements in care delivery and patient outcomes. The synthesized insights in this executive summary provide a foundation for more detailed exploration and targeted action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intelligent Asthma Monitoring Devices Market, by Device Type

  • 8.1. Fixed Monitors
  • 8.2. Mobile Apps
  • 8.3. Smart Inhalers
  • 8.4. Wearable Trackers
    • 8.4.1. Patches
      • 8.4.1.1. Adhesive
      • 8.4.1.2. Strap
    • 8.4.2. Wristbands

9. Intelligent Asthma Monitoring Devices Market, by Monitoring Technology

  • 9.1. Acoustic Sensors
  • 9.2. Biosensors
    • 9.2.1. Chemical
    • 9.2.2. Optical
  • 9.3. Data Analytics
  • 9.4. Environmental Sensors

10. Intelligent Asthma Monitoring Devices Market, by Connectivity

  • 10.1. Bluetooth
    • 10.1.1. Ble
    • 10.1.2. Classic
  • 10.2. Cellular
  • 10.3. Wi-Fi
    • 10.3.1. Wi-Fi 5
    • 10.3.2. Wi-Fi 6

11. Intelligent Asthma Monitoring Devices Market, by End User

  • 11.1. Clinics
  • 11.2. Home Care
  • 11.3. Hospitals
  • 11.4. Research Laboratories

12. Intelligent Asthma Monitoring Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Retail

13. Intelligent Asthma Monitoring Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intelligent Asthma Monitoring Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intelligent Asthma Monitoring Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intelligent Asthma Monitoring Devices Market

17. China Intelligent Asthma Monitoring Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Adherium Limited
  • 18.6. AptarGroup, Inc.
  • 18.7. GE HealthCare Technologies Inc.
  • 18.8. Health Care Originals, Inc.
  • 18.9. Koninklijke Philips N.V.
  • 18.10. Microlife Corporation
  • 18.11. NDD Medical Technologies, Inc.
  • 18.12. Nihon Kohden Corporation
  • 18.13. NuvoAir AB
  • 18.14. Omron Healthcare Co., Ltd.
  • 18.15. Phosphorus, Inc.
  • 18.16. ResMed Inc.
  • 18.17. Teva Pharmaceutical Industries Ltd.
  • 18.18. Vitalograph Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY FIXED MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY FIXED MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY FIXED MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SMART INHALERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY STRAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY STRAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY STRAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WRISTBANDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WRISTBANDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WRISTBANDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ACOUSTIC SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ACOUSTIC SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ACOUSTIC SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY OPTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY OPTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY OPTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DATA ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DATA ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ENVIRONMENTAL SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLASSIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLASSIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLASSIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CELLULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 5, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 5, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 5, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 6, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 6, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI 6, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 200. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 203. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 205. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 206. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GCC INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 233. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 234. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 236. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 238. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 239. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. G7 INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 244. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 247. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 249. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 250. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. NATO INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WEARABLE TRACKERS, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY PATCHES, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY MONITORING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BIOSENSORS, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY BLUETOOTH, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY WI-FI, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA INTELLIGENT ASTHMA MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)